Your Messages Inbox
Your Article Summary
See Latest ArticlesExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
b3c newswire, 07/09/09
ExcellGene SA, a leading provider of contract manufacturing to the biopharmaceutical industry, expands its product offering with the introduction of the 250 Liter OrbShake bioreactor. OrbShake bioreactors rely on orbital shaking principles for mixing compared to stirring or wave-like movements in order to achieve a superior oxygen transfer while minimizing shear forces. The OrbShake bioreactors were developed jointly with Sartorius Stedim Biotech and Adolf Kühner AG.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09
Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09
Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09
Article Search
Sponsor